Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Thorley

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Cell|January 1, 1979
Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cellsD A Thorley-Lawson
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1980
The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cellD A Thorley-Lawson
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1981
The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferonD A Thorley-Lawson
Nature Reviews. Immunology|March 22, 2002
Epstein-Barr virus: exploiting the immune systemD A Thorley-Lawson
Current Topics in Microbiology and Immunology|October 2, 2015
EBV Persistence--Introducing the VirusDavid A Thorley-Lawson
The Journal of Allergy and Clinical Immunology|August 9, 2005
EBV the prototypical human tumor virus--just how bad is it?David A Thorley-Lawson
British Medical Journal (Clinical Research Ed.)|January 12, 1985
Progression of addiction careers in young adult solvent misusersB Davies, A Thorley, D O'Connor
The EMBO Journal|June 1, 1987
The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cellsS Swendeman, D A Thorley-Lawson
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1980
Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivityD A Thorley-Lawson, K Geilinger
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2014
EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cellsJin Qiu, David A Thorley-Lawson
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Cell|January 1, 1979
Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cellsD A Thorley-Lawson
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1980
The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cellD A Thorley-Lawson
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1981
The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferonD A Thorley-Lawson
Nature Reviews. Immunology|March 22, 2002
Epstein-Barr virus: exploiting the immune systemD A Thorley-Lawson
Current Topics in Microbiology and Immunology|October 2, 2015
EBV Persistence--Introducing the VirusDavid A Thorley-Lawson
The Journal of Allergy and Clinical Immunology|August 9, 2005
EBV the prototypical human tumor virus--just how bad is it?David A Thorley-Lawson
British Medical Journal (Clinical Research Ed.)|January 12, 1985
Progression of addiction careers in young adult solvent misusersB Davies, A Thorley, D O'Connor
The EMBO Journal|June 1, 1987
The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cellsS Swendeman, D A Thorley-Lawson
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1980
Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivityD A Thorley-Lawson, K Geilinger
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2014
EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cellsJin Qiu, David A Thorley-Lawson
Pageof 11